The Corporate Transparency Act (CTA) entered into force on Jan. 1, 2024. This federal legislation has introduced significant, new compliance burdens on Reporting Companies. Attorneys on Holland & Knight's Corporate Transparency Team can help you navigate this new law by advising on a Reporting Company's compliance obligations.

Holland & Knight is pleased to present its 2023 Private Equity Year in Review, which takes a look at the team's significant and intentional strategic growth, successes for our clients and firm, and spotlights of key transactions, among other highlights.

For the first time, Holland & Knight has been named the largest healthcare law firm in the U.S. by Modern Healthcare, a leading source of healthcare business and policy news, research and information. 

The U.S. Supreme Court ruled in Alice Corp. v. CLS Bank that laws of nature, natural phenomena and abstract ideas are not patentable. Using Alice, Holland & Knight's Intellectual Property Group has won several patent-infringement cases for clients. The attorneys challenged the patents at the outset, saving clients from costly discovery and prolonged litigation.

Facing unintended consequences from FDA policies on unapproved drugs that could have removed common medical gases from the market, the Compressed Gas Association turned to Holland & Knight's Public Policy & Regulation Group to achieve a legislative solution. The historic reforms that resulted helped to avoid a potentially catastrophic result for the industry.